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Lymphoid tissue inducer (LTi) cells are key components of the machinery required for the construction of the
lymphoid structures underlying immune responses. In this issue of Immunity, Vonarbourg et. al. (2010)
describe how these cells assume several different guises, each associated with different LTi functions.LTi (lymphoid tissue inducer cells) are
cells that appear in primitive lymphoid
organs (lymphoid analagen) that produce
lymphotoxin (LTa1b1) and tumor necrosis
factor (TNF) and thus stimulate the
mesenchymal cell production of chemo-
kines and adhesion molecules essential
for lymphoid organogenesis (Mebius,
2003). These cells are innate cells in that
they do not develop in the thymus and
lack antigen-specific receptors; instead
they respond to cytokines induced by
innate stimuli or, as discussed below, via
NK cell-type receptor ligands. LTi cells
express retinoic acid receptor-related
orphan receptor (RORgt or RORC) tran-
scription factor as well as interleukin
(IL)-7Ra (CD127), and, indeed, these
components are necessary for the gener-
ation of LTi cells as well as the lymphoid
structures they induce, such as the
Peyer’s patches (Eberl et al., 2004).
Although LTi cells are readily found in fetal
tissues, they are relatively rare in adult
tissues, perhaps reflecting the reduced
need of adult tissue to form new lymphoid
structures. However, in the intestine
where the latter need may be higher, one
finds larger numbers of LTi, particularly
associated with intestinal cryptopatches
and isolated lymphoid follicles (Vivier
et al., 2009; Colonna, 2009). Recently,
another subset of RORgt-expressing LTi
cells that bear NK cell receptors (such as
NKp46) have been identified (Colonna,
2009). These cells differ from conven-
tional NK cells in that they express little
or no NK1.1 or perforin. In addition, these
cells do not produce IFN-g upon stimula-
tion with interleukin-12 (IL-12) but do
produce IL-22 in response to IL-23. The
advent of this subset has prompted spec-
ulation about the relation of LTi cells to NK
cells. In one theory, these cells arise from
a common precursor, which then gives
rise to either NK cells or NKp46+ RORgt+650 Immunity 33, November 24, 2010 ª2010LTi cells; in another theory, these cells
have separate lineages (Vivier et al.,
2009). In this issue of Immunity, Vonar-
bourg et al. (2010) define the relation of
NK cells to NK receptor+ LTi that do and
do not express RORgt; in doing so, they
more clearly define the role of RORgt in
LTi function.
In their initial studies, Vonarbourg et al.
(2010) show that in Rag2/Il2rg/ recip-
ientmice (lackingall lymphocytes) repleted
with purified NK cells or GFP-marked
NKp46-RORgt+ LTi cells (which express
sLTa1b1 and low perforin), the transferred
NK cells remain RORgt, whereas most
tranferred LTi cells upregulate NKp46. In
the small intestine of the recipient mouse,
RORgt expression in the transferred
RORgt+ cells is maintained, whereas in
the colon some cells lose RORgt. An
essentially similar result was obtained
with transfer of peripheral lymph node
cells. The results of these transfer studies
conducted in lymphopenic mice were
then confirmed in intact mice by studies
of fate-mapped mice in which cells that
have expressed RORgt at some point in
their life are engineered to permanently
express YFP. Here, it was found that all
NKp46+ cells were RORgt fate-mapped
cells and most small intestinal RORgt
fate-mapped cells express RORgt
whereas only 25% of colon or spleen cells
do so. These transfer and fate mapping
studies thus settle the question of the
origin of NKp46+RORgt+ LTi (NKR-LTi
cells): these cells arise from NKp46- LTi
precursors and then lose RORgt expres-
sion in certain lymphoid environments
(Figure 1). Finally, it should be noted that
loss of RORgt associated with lower
expression of CCR6, CD127, and sLTa1b1
and increased expession of perforin and
granzyme B. In other words such loss
causes diminished LTi function and
increased cytotoxic (NK-like) function.Elsevier Inc.In further studies, Vonarbourg et.al.
(2010) show that the loss of RORgt
expression in the NKR-LTi population is
determined by environmental factors. In
particular, they demonstrate that the gut
microbiota support persistance of RORgt
expression and germ-free mice lack
RORgt+ cells. Such microbial influence is
probably acting through the induction of
cytokines. Thus, whereas IL-15 and
IL-12 favor downregulation of RORgt,
IL-7 prevents downregulation, and IL-7R
deficient mice lack RORgt-LTi cells. In
contrast,TSLP, a cytokine that shares a
receptor chain with IL-7, has no effect
on downregulation.
In a final but very important series of
studies, Vonarbourg et.al. (2010) address
the effect of RORgt expression in NKR-
LTi cells on surface marker expression
and on cell function. Whereas RORgt+
NKR-LTi cells express high amounts of
sLTa1b1 and IL-7R, RORgt NKR-LTi
cells express perforin and granzyme. In
addition, RORgt expression correlates
with IL-23R expression and is highest in
CD4+ NKR-LTi cells. The significance of
this lies in the fact that IL-23R expression
leads to IL-23-dependent NKR-LTi pro-
duction of IL-22. Cells that express
RORgt are poorly responsive to IL-12
but gain responsiveness to this cytokine
as RORgt expression wanes; thus, RORgt
acts as a reostat for the ability to respond
to this cytokine. Overall, LTi cells that
retain RORgt expression maintain their
potential to act as inducer cells and
through the production of IL-22 maintain
a capacity to sustain epithelial cell integ-
rity whereas those that lose RORgt
expression tend to function as NK-like
cells in that they produce IFN-g and are
capable of cytotoxic function. It should
be noted, however, that CD4 RORgt
NKR-LTi cells that have lost RORgt ex-
pression during their sojourn in the colon
RORγt+ LTi cell
IL-7R LTα1β1



















Figure 1. Changes in Intenstinal LTi Populations during Maturation
In the fetal gut, the LTa1b1
+ LTi cell is an RORgt+ cell that does not yet express NKp46; this cell is poten-
tially capable of producing IL-17 and IL-22 but may not do so because of low IL-23 concentration at this
stage. In the neonatal gut lumenal microbiota are present and the LTi cell now expresses NKp46 and
becomes an NKR-LTi cell; this cell produces mainly IL-22 in response to IL-23. Finally, in the postnatal
period, LTi cells lose RORgt expression and become an LTi-derived NK cells; these cells can produce
IFN-g in response to IL-23 stimulation. Although this diagram describes the progression of LTi changes
over time, in reality, these various cells may coexist in the postnatal gut.
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those in the peripheral lymph nodes) and
these cells alone among LTi cells or NK
cells produce IFN-g in response to IL-23
stimulation (Figure 1). These cells are
potentially important in the light of
a concluding series of studies showing
that they are the subset of LTi cells that
has previously been linked to the induc-
tion anti-CD40-induced colitis in Rag2/
mice (Buonocore et al., 2010).
The relationship between RORgt
expression and IL-22 production induced
by IL-23 in LTi cells shown in these studies
andpreviouslyappears tobedifferent from
that in Th17 cells. Recall that in the latter
situation, RORgt expression is induced
by the cytokines TGF-b and IL-6 and
such induction leads to IL-23R expression
followed by differentiation and/or expan-
sion of Th17 cells by IL-23; thus, IL-23 is
only indirectly involved in Th17 cell IL-17
and IL-22 cytokine induction (McGeachy
et al., 2009). In contrast, LTi cells already
express RORgt yet do not produce IL-22
in the absence of IL-23, indicating that in
this case IL-23 has an inductive role and
that IL-23 signaling in LTi cells is differentfrom that in Th17 cells. Along related lines,
although NKp46 RORgt+ LTi cells
produce IL-17, NK46+RORgt+ LTi do not
(Cella, et al., 2009). Because RORgt is so
intimately associated with IL-17 produc-
tion, it seems likely that the lack of IL-17
production by the latter cells is not due to
an inductive defect but rather to suppres-
sion by factors in the intestinal tissues.
Whatever mechanism is involved, this
sudden loss of IL-17 producing capacity
may be fortuitous in that it renders the
NKR-LTR less proinflammatory.
These differences between Th17 and
LTi cells are reflected in the different role
of these cells in mucosal immune func-
tion. LTi cells have a distinct and unique
role as tissue inducer cells, and although
their function is most apparent early in
life when lymphoid structures are initially
forming, they also function in this manner
during adult life in response to infection in
peripheral tissue and most of the time in
the GI tract, which is constantly respond-
ing to new gut antigens. In addition, there
is now considerable evidence that LTi cell
production of IL-22 is an important host
defense element, particular in relation toImmunity 33, Ninfectious insults involving the intestinal
epithelium, such asCitrobacter rodentium
infection (Vivier, et al., 2009; Colonna,
2009). This can be attributed to the fact
that IL-22 been shown to preserve the
integrity of the epithelium and to induce
epithelial cell production of factors that
are cytotoxic for potential bacterial
invaders (Cella et al., 2009). Th17 cells,
on the other hand, are more clearly proin-
flammatory cells which, via the produc-
tion of IL-17, cause the influx of other
inflammatory cells as well as secondary
proinflammatory cytokines, including
those generated by the inflammasome.
So it appears that although LTi cells are
geared to prevent or avoid inflammation,
Th17 cells are geared to cause
inflammation.
The above discussion of the roles of LTi
cells and Th17 cells (or indeed Th1 cells)
brings us to the important question raised
in these studies of whether LTi cells
participate in causing inflammation in
inflammatory bowel disease (Crohn’s
disease; CD). This possibility was posed
initially by studies already alluded to
showing that LTi cells producing IL-17
and IFN-g are responsible for colitis
induced in (lymphopenic) Rag2/ mice
with Helicobacter hepaticus infection or
by LTi cells producing IFN-g in Rag2/
mice with anti-CD40-induced colitis (Buo-
nocore, et al., 2010) . As mentioned
above, in the studies by Vonarbourg
et al. (2010), the LTi cells causing anti-
CD40 colitis were identified as cells that
have lost RORgt expression and that
respond to IL-23 with IFN-g production.
However, in studies of patients with
Crohn’s disease addressing whether LTi
cells are involved in disease pathogen-
esis, it was shown that cells bearing an
NK marker (NKp44) and expressing
RORgt and CD127 are actually decreased
in the lamina propria, and this cell popula-
tion is not a source of increased IFN-g
production. In contrast, cells bearing NK
markers (including NKp46 and CD56)
and lacking the LTi marker CD127 are
increased in CD and do produce
increased amounts of IFN-g in this
disease. These cells, however, appear to
be NK cells not derived from LTi cells
(Takayama et al., 2010). One must there-
fore conclude that although various kinds
of LTi cells canmediate colitis in a lympho-
penic host, they do not do so in humans
with inflammatory bowel disease.ovember 24, 2010 ª2010 Elsevier Inc. 651
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Infection with intracellular pathogens triggers cytokine production in the infected cells. In this issue of Immu-
nity, Kasper et al. (2010) demonstrate that in certain infections, much of the response is mounted by nonin-
fected neighboring cells.The epithelial surface is a key portal of
entry for pathogens. However, invading
pathogens are detected by pattern recog-
nition receptors (PRRs),which activate the
appropriate innate defenses (Ting et al.,
2010). Dependingon the typeand thecon-
text of stimulation, sensing of the path-
ogen could trigger the activation of inflam-
masome, which facilitates maturation and
secretion of preformed interleukin (IL)-1
family members and/or the expression of
antimicrobial compounds, chemokines,
and cytokines such as IL-8. The chemoat-
tractants recruit phagocytes to the site of
infection to facilitate pathogen elimination
and initiate adaptive immune responses.
The mucosal epithelium was regarded
as a passive element, contributing to
host defense mainly by forming an imper-
meable, tight-junction-fortified monolayer
prohibiting microbial access to the under-
lying tissue. This view has changed over
the past decade as it became clear that
epithelial cells express PRRs, including
the Nod-like receptors Nod1 and Nod2,
and that these PRRs recognize microbial
products leading to the secretion of proin-
flammatory cytokines (Artis, 2008; Ting
et al., 2010). Thus, infected epithelial cells
produce key cytokines (e.g., IL-8,
CXCL-2, TNF-a, GM-CSF), attract phago-cytic cells, and ultimately orchestrate
innate immune defense and initiate adap-
tive immunity (Eckmann and Kagnoff,
2005). Therefore, epithelia do play an
active role in coordinating defense.
Based on classical receptor-response
mechanisms, it has been assumed that
the proinflammatory cytokines are pro-
duced by the infected cell itself. This
made sense as each epithelial cell har-
bored the PRRand the signaling cascades
for driving cytokine expression. However,
in this issue of Immunity, Kasper et al.
(2010) demonstrate a substantial contribu-
tion of the response came from the nonin-
fected bystander cells. This study em-
ployed the invasive pathogen Shigella
flexneri to study signaling of the NF-kB
transcription factor pathway, as well as
JNK, ERK, and p38 kinase activation and
IL-8 secretion at the single cell level.
Upon invasion, S. flexneri enters the host
cell’s cytosol, where it is recognized by
Nod1, activating NF-kB, JNK-, and ERK
and p38 signaling and inducing IL-8 secre-
tion (Figure 1). Surprisingly, NF-kB, JNK,
ERK, and p38 signaling and IL-8 secretion
occurred not only in the infected cell itself
but also in the surrounding, noninfected
bystander cells. Notably, bystander acti-
vation occurred by 30 min of infectionand the cytokine release by the bystander
cells was even more pronounced than
that of the infected cell itself. Therefore,
the bystander cells amplified the defense
signal within the infected epithelium.
Bystander cell activation has also been
identified in a parallel study of the Gram-
positive pathogen Listeria monocytogenes
(Dolowschiak et al., 2010). Soon after this
pathogenhasreachedthecytosolofmurine
intestinal mICcl2 cells, the noninfected
bystander cells begin expressing the che-
mokines CXCL5 and CXCL2, a murine
IL-8 homolog (Figure 1). Notably, both
studies excluded the possibility that
bystander cells are activated by paracrine
signaling, e.g., by cytokines released from
the infected cells. Thus, bystander activa-
tion is a new mechanism of general impor-
tance for defense against various intracel-
lular pathogens.
It seems surprising that bystander cell
activation has not been observed earlier.
This is most likely linked to the types of
reagents and assays generally used in the
field. Most studies of innate immunity have
employed purified pathogen-derivedmole-
cules, an approach prohibiting differential
analysis of direct and indirect activation.
Single cell analysis of bacterial infection
has circumvented this technical problem.
